Estimated health and economic benefits in Canada of reduced tuberculosis transmission in key source countries of immigration: a Markov modelling analysis
A Markov microsimulation study predicts that reducing tuberculosis transmission in high-burden source countries, particularly India and the Philippines, would generate significant downstream health and economic benefits for foreign-born Canadians between 2025 and 2050.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Tuberculosis is an ancient bacterial infection that still claims more lives today than any other single infectious disease. It spreads through the air when an infected person coughs, and while it can be cured, it often lies dormant inside a person for years, waking up to cause severe illness only when the immune system weakens. In countries like Canada, where the disease is rare, most new cases do not come from local transmission. Instead, they occur in people who were born elsewhere and carried the infection with them before arriving. These individuals often acquired the bacteria decades ago, in their home countries, and the infection only becomes active after they have settled in their new home. This reality creates a unique challenge: the disease is not spreading within Canada's borders, but its roots are planted in the soil of nations where the infection is still common.
A team of researchers at McGill University decided to look at this global connection through a different lens. Rather than asking how to stop the disease once it arrives in Canada, they asked what would happen if the disease were stopped before the people ever left their home countries. They focused on four nations that are major sources of immigration to Canada: China, India, the Philippines, and Vietnam. Using a sophisticated computer simulation, the researchers modeled the flow of people and the spread of infection over the next few decades. They imagined a scenario where these four countries successfully reduced the rate at which people catch the tuberculosis bacteria, and then they calculated the ripple effects of that success on the Canadian healthcare system.
The study did not test a specific medicine or a new vaccine. Instead, it acted as a mathematical crystal ball, projecting what would happen between the years 2025 and 2050 if these countries managed to lower the annual risk of infection by small, steady amounts. The researchers built a model that tracked millions of people, simulating their lives from the moment they arrived in Canada until the end of the century. They accounted for how many people would arrive, how likely they were to carry the bacteria, and how often that bacteria would wake up to cause active disease. They then compared this "business as usual" path against four new paths where the risk of infection dropped by one, two, three, or four percent each year beyond the current trends.
The results of this simulation pointed to a clear and significant opportunity. The researchers found that even modest improvements in tuberculosis control in India and the Philippines would yield the largest benefits for Canada. In the scenario where infection rates in India dropped by just one percent annually, the model predicted that dozens of new cases of active tuberculosis would be prevented among Indian immigrants over the next twenty-five years. If that reduction reached four percent, the number of prevented cases would climb into the hundreds. The Philippines showed a similar pattern, with the potential to prevent hundreds of cases under the same conditions. These prevented cases translate directly into money saved and lives extended. The study calculated that for every quality-adjusted life year gained—a standard measure that combines how long a person lives with how well they live—the investment in overseas prevention would generate a substantial return for the Canadian healthcare system.
The financial impact was most pronounced for immigrants from India and the Philippines. The simulation suggested that the Canadian healthcare system could save between 3.4 and 12 million dollars by preventing cases among people from India, and between 2.4 and 8.6 million dollars for those from the Philippines, depending on how successful the overseas programs were. While the savings for immigrants from China and Vietnam were also positive, they were smaller in total dollar amount. This difference was not because the disease was less dangerous in those countries, but because fewer people were arriving from Vietnam, and the infection rates among those arriving from China were already lower. The model showed that the benefits were not just about saving money on treatment; they were about preventing the suffering and premature death that comes with active tuberculosis.
The researchers were careful to note that these numbers represent only the portion of the benefit that Canada would enjoy. The improvements in India or the Philippines would save countless lives and prevent immense suffering within those countries themselves. The gains calculated for Canada are simply the downstream echo of a much larger global success. The study also highlighted that the current trend of reducing infection rates in these countries is already happening, but accelerating that progress could prevent a significant number of future cases. The authors emphasized that their work does not prove that a specific intervention will work, but rather suggests that the strategy of investing in health abroad is a powerful tool for protecting health at home.
This analysis challenges the idea that a country with low disease rates must only look inward to solve its health problems. By treating tuberculosis as a global issue, the study suggests that the most effective way to protect a population in a low-risk country might be to support the health systems of the high-risk countries that supply its immigrants. The simulation provides a concrete picture of what is possible: if the world can reduce the risk of infection in key source nations, the rewards will be felt in the clinics and hospitals of Canada, in the form of fewer sick patients, lower costs, and more years of healthy life for the people who call Canada home.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.